SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017789
Filing Date
2022-11-14
Accepted
2022-11-14 16:31:57
Documents
44
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpth-20220930x10q.htm   iXBRL 10-Q 775137
2 EX-31 bpth-20220930xex31.htm EX-31 12494
3 EX-32 bpth-20220930xex32.htm EX-32 6295
  Complete submission text file 0001558370-22-017789.txt   2667769

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpth-20220930.xsd EX-101.SCH 26990
5 EX-101.CAL bpth-20220930_cal.xml EX-101.CAL 22035
6 EX-101.DEF bpth-20220930_def.xml EX-101.DEF 66981
7 EX-101.LAB bpth-20220930_lab.xml EX-101.LAB 188239
8 EX-101.PRE bpth-20220930_pre.xml EX-101.PRE 154689
38 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20220930x10q_htm.xml XML 248776
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36333 | Film No.: 221386443
SIC: 2834 Pharmaceutical Preparations